BridgeBio Pharma, Inc. (BBIO) stock
BBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 3/30
$78.01+1.21 (+1.58%)
Close on Nov 18, 2026Market cap $15.20BP/E –Yield –
BridgeBio Pharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
BridgeBio Pharma's price to book ratio was 118.6× on Apr 30, 2021, against 9.2× a year earlier.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Apr 30, 2021 | 118.6× | +65.4 |
| 2020 | Dec 31, 2020 | 53.2× | +44.3 |
| 2019 | Dec 31, 2019 | 8.9× | – |
See a number that looks wrong?